Abstract:

Purpose: We aimed to study the role of the average volume of thrombocytes with serum uric acid and laktate levels in predicting the success of treatment in patients with ischemic immaculation. Methods: The study included 115 patients diagnosed with cerebrovascular disease and received thrombolithic or thrombectomy treatment. Patients were divided into two groups as the complication developed and undeveloped. Demographic characteristics, laboratory findings, National Institutes of Health’s Admission and Dismissal Score and Modified Rankin Score (mRS) scores were reviewed backward. Results: 58.1% of all patients were male. There was no difference in laboratory parameters between the groups. The NIHSS score in the application, the NIHSS score in departure and the mRS score were significantly higher in the group developing after treatment complications (p<0,05). Laboratory values showed no significant differences between the groups. The rate of early deaths was significantly higher compared to the non-developed group of complications in the developing group of complications (p<0,05). The single variable model demonstrated the meaningful effectiveness of the NIHSS score and the mRS score in the complicated and non-complicated patient distinction (p<0,05). In the multi-variable model, a meaningful and independent effect of the NIHSS score in discharge was observed in the complicated and uncomplicated patient distinction (sensitivity = 83.3%, positive forecast = 30.8%, specificity = 57.1%, and negative forecast = 93.8; p<0.05). The result: We did not find a meaningful relationship between the development of complications after trombolithic treatment and laboratory findings. NIHSS score complications can be a suitable parameter in prediction.

Keywords: